2 Introduction to modeling chemical reactions
Mass-action kinetics
We generated an ordinary differential equation (ODE) for every species using mass-action kinetics for each binding reaction. The law of mass action states that the rate of a chemical reaction is proportional to the product of the concentration of the reactants raised to the power of their stoichiometric coefficient. For example, consider the one-reaction system:
where the forward and backward rates are k 1 and k 2 . The differential equations describing the dynamics of species X, Y , and Z under mass-action kinetics are:
Mass action kinetics rely on the assumption that the rate constant, k, is constant over time. However, within a restricted space such as a membrane, the rate constant may change over time due to restricted diffusion and mass action kinetics may not be accurate [3] . We assumed that most binding interactions occur rapidly enough such that k remains constant.
Michaelis-Menten kinetics
We used Michaelis-Menten kinetics to model enzyme-catalyzed reactions. When a reaction is catalyzed by an enzyme with kinetic properties k cat and K M , S E P, then the reaction rate is given by
For Michaelis-Menten kinetics to apply, the concentrations of the reactants and products must be in large enough quantities, and one of the following conditions must apply:
1. The concentration of substrate is very much larger than the concentration of products: [S] [P].
2. The energy released in the reaction is very large: ∆G 0.
Transport between compartments
Flux between different cellular compartments was modeled as a reaction rate that captures the rate of species transport per unit time. For the transport of species A between compartments c and d, we used rate equations of the form
where k 1 and k 2 are the transport in and out of compartment c respectively. When utilizing flux for compartmental transport it is important to note the interaction is only valid when the compartments are large and the corresponding surface area conversion factors are accounted for. 3 Model development for growth-factor based cAMP signaling
Phenomenological model
We defined a simple, phenomenological model for the system based on information from legacy literature, Figure 1A , simple fluxes were chosen to capture the biochemical interactions with a minimal number of components. The phenomenological model aims to identify the 'minimal' network module that can capture the interactions of EGFR, GIV, and G proteins to modulate cAMP flux, independent of parameter values. We define these interactions as follows: Table S1 : Description of the simplified interactions of the phenomenological model. 
Reaction Explanation k 2 [EGFR(t)][EGF(t)]S(t) S(t)
=1
(t)][GEF(t)])
inhibition of AC -decreases basal rate as a function of EGFR and GEF k AC [EGFR * 2i (t − δ 1 )] activation of AC -assumed as a function delayed on internal EGFR concentration EGF is presented as a stimulus from 0 to 30 minutes with constant value on 1 and 0 at all other times. This mirrors stimulus used in experimental conditions. EGFR and cAMP concentrations are initialized at 1. GIV concentration is set by mass conservation GIV = 1 − [GEF ] − [GDI] . All other initial conditions are set to 0. The phenomenological model was then modeling by the following ODEs. This model has 3 time delays, 15 kinetic parameters, and 7 variables. To constrain the model, a large range of possible parameters were simulated, as shown in Table S2 . Parameter values are chosen though uniformly distributed values across x∈ [a, b] were the parameter is defined as 10 x . k base was set to be equal to k deg such that the steady state of cAMP is 1. The value of k base is assumed as it only encodes the basal degradation and production rates (which control max and min peak values). Simulations were conducted for 5000 runs and log-normal distributions were calculated and reported ( Figure 1) . A secondary variation was also performed with all parameters fixed except time delays, τ . The values for the variation are chosen from uniformly distributed values across x∈ [a, b] . 5000 runs for each simulation were conducted and normal distributions were calculated and reported ( Figure S1 ).
d[EGFR] dt = −k 2 [EGFR(t)][EGF(t)]S(t) + k r2 [EGF-EGFR(t)] d[EGF-EGFR] dt = k 2 [EGFR(t)][EGF(t)]S(t) − k r2 [EGF-EGFR(t)] − 2k 3 [EGF-EGFR(t)]

Sensitivity analysis of the phenomenological model
To determine the relative sensitivities of each parameter across the simulation time, variance-based sensitivity analysis was performed [4] [5] [6] . The analysis describes the sensitivities of the phenomenological model with respect to the uncertainty in kinetic parameters k. Given the model form, the first order effect of the factor X i on the variance is V Xi (E X∼i(Y |Xi) ), where X ∼i is the matrix of all factors but X i . When compared against the total variance, S i is retrieved, where
. The total index S T i does the same but considers all higher order effects of X i through calculation of E X∼i (V Xi (Y |X i )). To find these values, a hypercube composed of two independent sampling matrices A and B of size N x2k is created (where k is the number of uncertain parameters and N is the number of random samples). A third matrix is then sampled, A i B , defined as the matrix A with the i th column sampled from matrix B. We then define
2 . The solution in Figure S1 used N=20000 and i=14 (excluding time delays and the basal cAMP rates) and results are shown for the sensitivities across the complete simulation time (excluding small variance values, which are unreliable and insignificant).
Compartment sizes
We conducted simulations using the following compartments for a computational HeLa cell: cytoplasm, plasma membrane, endosome, endosomal membrane, and a nucleoplasm. We assumed that the cell was spherical shaped and used a cytosolic volume of 2000 µm 3 [7] . We assumed the endosomes to be fixed in size and surface area of 5 µm 2 using V = n 4 3 πr 3 and membrane area by A = n4πr 2 , where n is the final number of endosomes. The different compartment sizes are shown in Table S3 . 
Model Kinetics
We conducted simulations for 60 min based on the time course of RTK→cAMP signaling [2]. We did not account for the regeneration of ATP and PIP 2 , and assumed that these values are constant and high. We did not include mitogen-activated protein kinase (MAPK) or calcium pathways in this model. This model has 76 kinetic parameters of which 19 are fit and the remainder are taken from the literature. Of the 19 kinetic parameters that were fit, 7 of them affect cAMP dynamics but only 4 change the dynamics of cAMP.
Module 1: EGF Receptor Module
The receptor module captures the key events of 1. Ligand binding and dimerization.
2. Receptor activation and internalization.
3. Receptor endosomal recycling.
Receptor Gα
This module is based on Shoerberl et al.
[8] for EGFR activation, internalization, and recycling. Binding of EGFR to scaffolding proteins was not included in this model. Gα s ·GIV-GDI dependent degradation of EGFR was modeled based on [10] . Although the exact mechanism of Gα s -GDP based degradation is unknown, we used a constitutive model to capture the effect of degradation of EGFR by Gα s using a Gα s -GDP independent basal rate and a Gα s -GDP dependent catalytic rate. In this Module there are 10 reactions, 14 kinetic parameters. Of these, 3 were fit to experimental data (Figures 2, S3) 
Kinetic parameters
The kinetic binding parameters were chosen based on the values given in Schoeberl et al. [8] , Berkers et al. [11] , and French et al. [12] . The rate of EGF binding to EGFR at the plasma membrane was set through values reported in Berkers et al. [11] . The binding rate of endosomal EGF to EGFR was set by the relative ratio of pH=6 and pH=7.4 as shown in French et al. [12] . Degradation of EGFR was set through the global parameters k b , basal degradation, and k c , Gα s -GDP-dependent degradation. The internalization and degradation rates were modified to fit experimental data for receptor internalization as shown in [9, 13] and for experimental data shown in Figure 1E -F, S3.
Module 2: Transactivation of Gα i by EGFR via GIV-GEF interactions
The GIV-GEF module captures the key events of 1. Activation of GIV through CDK5.
2. GIV·EGFR binding and amplification of receptor signaling events.
3. Formation of EGFR·GIV·Gα i complex and activation of Gα i .
The activating step for GIV-GEF is CDK5-mediated phosphorylation of S1674 on GIV [2]. GIV-GEF is then later turned "off" by PKC-θ, which is activated downstream of PLC-γ. Once activated, GIV-GEF binds to EGFR and Gα i -GDP to assemble the EGFR·GIV·Gα i complex [14] . Previously published pathways, kinetics and dynamics of CDK5 activation were used to build the model [15] [16] [17] (see 'Kinetic parameters' section below). We did not track the dynamics of βγ in this model. In this Module there are 7 reactions, 14 kinetic parameters. Of these, 4 were fit to experimental data (Figures 2, S3 ).
Kinetic parameters
Kinetic parameters were determined through a combination values from the literature and experimental data fitting. Activation of p35 by the receptor (Table S5 reaction 12) , was determined using rates from Bhalla et al. [18] and by fitting simulations to new (cAMP timecourse) and previously published experimental data (GIV-GEM IB), Figure 1E -F, S2E-F, S3 , [2] . The rate of p35 degradation was determined based on the known half-life of 20 to 30 min [19] then refit to the GIV-GEF curve, Figure S3 . Maximum binding of CDK5 to p35 (Table S5 reaction 13), was set to 80% based on published experimental data [15] . Binding of CDK5 to active p35 was assumed to be very rapid. The rate of GIV-GEF activation by CDK5 (Table S5 reaction 14) , was fit to immunoblotting data [2] ( Figure 1E -F, S2E-F, S3). EGFR 2 ·GIV and EGFR·GIV·Gα i formation rates were determined by fitting of experimental data using COPASI [20] and using the experimentally determined dissociation constant (K d ) of EGFR·GIV·Gα i formation [14, 21] .
Module 3: Transinhibition of Gα s by EGFR via GIV-GDI
The GIV-GDI module captures the key events of 1. PLC-γ activation and PIP 2 hydrolysis.
2. Enhanced PLC-γ activation through EGFR 2 ·GIV.
3. DAG dependent PKC-θ activity.
4. Termination of GIV-GEF [for Gα i ], and its conversion to GIV-GDI through PKC-θ and reduction of GEF activity.
The action of PKC-θ on GIV was based on prior work [2] , which showed that targeted phosphorylation on site S1689 terminates GIV's GEF function, only allowing GDI function to be active. For the purposes of our model, it was assumed that the PLC-γ→PKC-θ axis acts after CDK5, as shown previously [2] . In doing so, the PLC-γ→PKC-θ axis phosphorylates GIV-GEF that is activated by CDK5, but not inactive GIV [2] .
In the model, activation of PKC-θ was achieved through the action of PLC-γ. PLC-γ activation was modeled to be a function of both EGFR and EGFR 2 ·GIV; the latter assumption was made based on prior work [14] , which showed that GIV enhances EGF triggered PLC-γ signaling. Once active, PLC-γ hydrolyzes PIP 2 , creating IP 3 and DAG [22] ; DAG then binds and activates PKC-θ, inducing the localization of the latter to the PM. PKC-θ then phosphorylates GIV-GEF in both the unbound and the receptor bound form. Gα s ·GIV-GDI complex formation and function was based on [2, 10] where it was shown to only act of the GDP form of Gα s . In this Module there are 11 reactions, 16 kinetic parameters. Of these, 6 were fit to experimental data (Figures 2, S3 ).
Kinetic parameters
The initial choice of kinetic parameters were based on the previously published rates for activation of PLC-γ, PIP 2 , and IP 3 degradation [18] . These parameters were then refined by fitting the dynamics of the Gα s ·GIV-GDI complex to immunobloting data [2] ( Figure 1E -F, S2E-F, S3); the rate of GDI activation through PKC-θ and the rate of formation of the Gα s ·GIV-GDI complex were determined by fitting simulations to immunoblot data ( Figure 1E -F, S2E-F, S3).
Module 4: Reactions for the production and degradation of cAMP
The cAMP module captures the key events of 1. Inhibition of basal activity of the PM-pool of AC by Gα i .
2. Activation of endosome-pool of AC by Gα s .
3. Internalization of AC, Gα s , Gα i .
4. Production of cAMP, activation of PKA, and PDE.
In the model, we assumed that AC activation through EGFR occurs only on the endosome [16, 23] , because we assumed that EGFR is only able to activate G s proteins on the endosome. Binding of internalized Gα s -GTP to AC activates and allows increased catalytic activity of AC [24] . The binding of Gα i to AC was modeled to reflect the inhibition of all AC activity [25] . AC inhibition was allowed to occur on both membranes.
cAMP production by AC was modeled with Michaelis-Menten kinetics [24] . Because cellular ATP is in the millimolar range [26] , a large excess compared to the concentrations of the signaling molecules, the concentration of ATP was assumed to be constant. Once four cAMP molecules bind to the four distinct binding sites on PKA, the quadruple occupancy leads to activation of the catalytic subunit, PKAc, which separates from regulatory subunit [27] . In our model, PKA activation was modeled using a Hill equation [28] . We assumed that PKAc had the same steady state concentration in the nucleosol as the cytosol. PDE activation through PKAc and enzymatic function was based on [24] ; cAMP is degraded by PDE. We did not consider any AKAPs or AKIPs because they fall outside the scope of the current model; it possible that their inclusion may impact response strength and timescales. In this Module there are 23 reactions, 14 kinetic parameters. Of these, 3 were fit to experimental data (Figures 2, 3 , and S3 were fit to Figure S8 ). Figure 1E -F, S2E-F, S3). The kinetic rates governing PKA activity were determined by using steady state dose-response curves to fit a Hill equation ( Figure S8) [28], dissociation of cAMP from the regulatory subunits [32] , and reformation of the PKA holoenzyme.
Role of additional interactions from CDK5 and PKC-θ to PDE
Previous studies have shown that both CDK5 [33] and PKC-θ [34] influence PDE activation. We modeled interactions of CDK5 and PKC-θ to activation of PDE, leading to further suppression of the cAMP signal; the additional interactions are shown in Table S9 . The addition of these interactions did not alter the time course of cAMP production but reduced the amount of cAMP produced Figure S9 .
Kinetic parameters
We tested the role of additional PDE activation pathways through 34] ; We assumed these interactions would double the maximum PDE concentration based on previously published data [33, 34] that has shown that suppressing the affects of CDK5 and PKC-θ on PDE reduced PDE activity by 1.25 to 1.5-fold.
Parameter estimation, model access, and additional results
The simulations for the phenomenological network, shown in Figure 1 , were carried out in MATLAB using dde23. The MATLAB files used to generate results can be found in supplementary files under the name GETZ 2019 cAMP.m ( Figure 1 ) and GETZ 2019 cAMP timedelay.m ( Figure S1E ). Code for the variance based sensitivity is GETZ 2019 cAMP sens.m ( Figure S1 ).
The simulations for the full network, shown in Figure 2 , were carried out in COPASI. The COPASI files used to generate results can be found in supplementary files under the name GETZ 2019 cAMP full.m (Figure 2 ), GETZ 2019 cAMP full PM EM.m ( Figure S5 ), and GETZ 2019 cAMP full feedback.m ( Figure S9 ). CO-PASI (http://copasi.org/) is supported by National Institutes of Health, NIH (USA) (Grant GM080219 NIGMS), BBSRC (UK) (Grant BB/J019259/1), and BMBF Federal Ministry of Education (Germany). Previous versions of the full model were build in the Virtual Cell [VCell] . The Virtual Cell is supported by NIH Grant Number P41 GM103313 from the National Institute for General Medical Sciences. A detailed protocol/user guide on how to develop models in Virtual Cell has been published elsewhere [35, 36] .
Parameter estimation with COPASI
Parameter estimation was originally carried out using COPASI [20] built into the VCell program [35] . Parameter estimation was then expanded into the COPASI environment. Fitting was conducted simultaneously on GIV-GEF(IB), GIV-GDI(IB), cAMP(RIA), EGFR·GIV·Gα i (IB), and Gα s ·GIV-GDI (PLA) data with respective initial values (IB carries a higher initial GIV concentration due to experimental over expression).
The particular estimation method used was evolutionary programming (EP) for 300 generations with a 25 population size using 1 random number generator. This was performed for two runs before results were reported. Evolutionary programming functions as follows: once presented with a optimization problem, i.e. minimizing error between the absolute values of experimental data and simulation data (E=|y 1 − y 2 |), the algorithm develops a set of potential solutions by varying parameters chosen by the user. At the next "generation" each individual solution produces two "offspring" one of the same solution and one with slight random parameter variations. Therefore, at the end of this generation there are double the number of potential solutions. These are then reduced to the original number of solutions by comparing the error against the other solutions, keeping only the lowest errors and deleting all other solutions. For more information on this method see [37] .
EGFR dynamics at the plasma membrane and the endosomal membrane
Module 1 of the reaction network models the dynamics of EGFR at the PM and the endosome ( Figure S2A , Table S4 ). At the PM, EGFR is activated by ligand binding, receptor dimerization, and cross-phosphorylation; activated EGFR is internalized to the early endosome through endocytosis, from where it can be either recycled or degraded [8] . Active PM EGFR also forms a complex with GIV-GEM, and via GIV with Gα i , leading to the activation of Gα i [2] . On the other hand, while it remains unclear when and where EGF/EGFR activates Gα s , it is known that a pool of GIV that is on endosomes containing internalized EGFR binds and inactivates Gα s on the endosomal membrane. Once inactivated, Gα s -GDP enhances the degradation rate of internalized, endosomal EGFR, thereby limiting the pool of receptors available for recycling to the PM and serves to attenuate growth factor signaling [10] .
Simulations from the model show that EGFR dynamics is governed by multiple time-scales when ligand stimulation triggers the redistribution of receptors from the PM to different pools ( Figure S5A ). The PMpool of active receptors increases rapidly upon ligand stimulation ( Figure S5A , red line) and subsequently recruits GIV, forming GIV-GEF·EGFR complexes ( Figure S5A , purple line). The endosomal pool of active receptors increases at a slower time scale ( Figure S5A , yellow line) than the PM-pool of active receptors.
Recycling of the endosomal pool of receptors to the PM leads to a small second burst in the PM pool of receptors around 10 min ( Figure S5A , yellow line). These findings are in agreement with Schoeberl et al. [8] , indicating that our model accurately captures the EGFR dynamics. The total number of active receptors decreases over time because of Gα s -GDP-dependent receptor degradation ( Figure S5A , blue line). The pool of receptors in the GIV-GEF·EGFR complex subsequently interact with Gα i at the PM to form the EGFR·GIV·Gα i complex. The effect of kinetic parameters of EGFR dynamics is shown in Figure S7A Cand we find that the balance of PM-pool versus internalized pool of EGFR is closely regulated by both the internalization rate and the Gα s -GDP dependent receptor degradation rate [10].
Dynamics of Gα i signaling: activation kinetics are shaped by both upstream EGFR dynamics and downstream PLC-γ→ DAG →PKC-θ signaling events
We next asked how EGFR dynamics affect the dynamics of Gα i signaling at the PM. Activation of EGFR at the PM triggers a series of downstream events, including the activation of CDK5 at the PM by its cofactor, p35 [38] . CDK5 phosphorylates GIV at Ser(S)1675 and enhances GIV's ability to bind Gα i , i.e., CDK5 turns inactive GIV to into active GIV-GEF [39] . This allows GIV to couple Gα i to EGFR by assembling ternary EGFR·GIV·Gα i complexes at the PM [40] and activate Gα i in the vicinity of ligand-activated EGFR (Module 2 in the model, Figure S2A , Table S4 , S5) . EGFR also triggers the activation of the PLC-γ-DAG-PKC-θ pathway [41]; PKC-θ phosphorylates GIV at S1689 and terminates GIV GEF activity towards Gα i [42] . Such sequential phosphorylation has another function -it converts GIV that is a GEF for Gα i (GIV-GEF) into GIV that now serves as a GDI for Gα s (GIV-GDI); GIV-GDI binds and inhibits GDP exchange on Gα s [2].
We asked, how do the CDK5 and the PLC-γ pathways regulate dynamics of the EGFR·GIV·Gα i complex formation, which is the key precursor event essential for transactivation of Gα i by EGF/EGFR [40, 43] .
Sensitivity analyses showed that despite the substantial number of model parameters (Tables S12 and S15), the formation of the EGFR·GIV·Gα i complex is sensitive only to a few kinetic parameters and initial conditions over time (Tables S12 and S15, Figure S7 ). For example, a ten-fold variation of the forward rate for the binding of GIV-GEF to the activated receptor (k f in reaction 15, Table S5 ) affected the peak values of the complex formation but not the temporal features of the EGFR·GIV·Gα i complex formation ( Figure S7D) . Similarly, the activation of the GIV-GEF function by CDK5 (reaction 14, Table S5 ) affected the density of the complex but not the temporal dynamics ( Figure S7E ).
The dynamics of the EGFR·GIV·Gα i complexes, however, were sensitive to the initial concentrations of Gα i (expected), GIV (expected), Cdk5 (expected), PIP 2 (unexpected) and PLC-γ (unexpected) ( Table S12 ). The sensitivity of EGFR·GIV·Gα i complex formation to PIP 2 and PLC-γ likely stems from network crosstalk, because the PLC-γ→DAG→PKC-θ pathway terminates GIV-GEF, triggering the dissociation of GIV and Gα i , which triggers the disassembly of the EGFR·GIV·Gα i complexes ( Figures S2A, S2B ). Changes in PLC-γ impacted both the density and temporal dynamics of the EGFR·GIV·Gα i complexes. As expected, when the PLC-γ→DAG→PKC-θ pathway is inhibited, the lifetime of GIV-GEF is prolonged and vice versa. This effect is evident when comparing the normalized densities against experiments ( Figure S7F ).
We conclude that early activation of GIV-GEF, and the observed dynamics of the assembly of EGFR·GIV·Gα i complexes are not only dependent on the upstream kinetics of EGFR activation, but also on the downstream conversion of GIV-GEF to GIV-GDI, mediated by the PLC-γ→DAG→PKC-θ pathway. Findings also indicate that the connections within the network effectively capture the dynamics of transactivation of Gα i by EGFR via GIV-GEF.
Dynamics of Gα s activation is most compatible with delayed activation triggered by internalized EGFR and inactivation by GIV-GEM on endosomes
Although GIV-GDI inhibits the activity of Gα , we reasoned that computationally predicted dynamics of all three possible scenarios of compartmentalized Gα s activation i.e. [1) exclusively at the PM 2) exclusively at the endosomes; and 3) both at the PM and then on the endosomes ( Figure S5B ), can provide insights into which option might be in accordance with the actual observed time scales for the same.
In the first scenario, where ligand-activated EGFR triggers Gα s activation exclusively at the PM, activation is predicted to be rapid with peak concentration at 35 sec, similar to the case of β2-adrenergic receptors peak activity at 15 sec [46] (also see Figure S5C ); this kinetic pattern mimics the dynamics of rapid EGFR activation at the PM. In the second scenario, where ligand-activated EGFR triggers Gα s activation exclusively on endosomal membranes, the time of peak activity is around 15 min ( Figure S5C , red line), in accordance with the time scales of Gα s activation and cAMP production [2] . Finally, if we consider a scenario where ligand-activated EGFR triggers Gα s activation both at the PM and on endosomes, we observe a first peak of rapid activation at around 35 sec, followed by a second burst at around 15 min. In all three scenarios, activation of Gα s [concentration of Gα s -GTP] was higher in the absence of GIV's GDI activity (i.e., when the concentration of GIV is set to zero; Figure S5C ). Based on the dynamics of EGFR at the PM [rapid, almost instantaneous] and on the endosome [approximately 10 min] ( Figure S5A ) and similar timescales for Gα s activation observed from the different modes of Gα s activation ( Figure S2E ), we predict that Gα s is likely activated on endosomes.
To validate model predictions, we used a Gα s conformational biosensor, nanobody Nb37-GFP that binds and helps detect the nucleotide-free intermediate during Gα s activation [2] . Prior studies have extensively validated this tool and demonstrated its ability to detect Gα s activation in real time, both at the PM (seen as a burst of signal in the cell periphery) and within early and recycling endoscomes (seen as dynamic punctate vesicles inside cells [1, [47] [48] [49] . In control cells, no significant Gα s activity was detected, neither at the PM, nor on endosomes, neither before, nor after ligand stimulation, indicating that Gα s is either not activated after EGF stimulation or that its activity is efficiently suppressed by some modulator, presumably Finally, we evaluated the dynamics of formation of the Gα s ·GIV-GDI complex [Module 2; Figure 1F ], the precursor event that is essential for transinhibition of Gα s by EGF/EGFR [2] . Our model for the dynamics of assembly of Gα s ·GIV-GDI complexes ( Table S4, S6, S7) included the kinetics of receptor internalization, Gα s activation by internalized receptors, conversion of GIV-GEF to GIV-GDI by the PLC-γ→DAG→PKC-θ pathway, and the Gα s -GDP-dependent degradation of endosomal EGFR ( Figure S2A) . Simulations from this model showed a good qualitative agreement between normalized Gα s ·GIV-GDI complex formation between model and cell-based experiments [2].
The role of kinetic parameters and initial conditions affecting the formation of the Gα s ·GIV-GDI complex were explored in detail ( Figure S7 ) and we found that the dynamics of Gα s ·GIV-GDI complex formation is more sensitive to internalization and degradation of EGFR than to any other kinetic parameters. However, our model was unable to capture the precipitous reduction in the normalized concentrations of Gα s ·GIV-GDI complexes at 60 min. We speculate that the discrepancy between model and experiment may stem from the fact that the model is fine-tuned to compute the Gα s ·GIV-GDI complexes that are located exclusively on the endosomes, whereas the experiment assessed Gα s ·GIV-GDI complexes in whole cells (not restricted to the endosomes) by proximity ligand assays (PLA) on endogenous proteins or by GST pulldown assays using cell lysates as source of Gα s . Experimentally, it is not yet possible to assess specifically the number of cytosolic versus endosomal vs other membrane-localized Gα s ·GIV-GDI complex numbers in living cells responding to EGF. Because Gα s on endosomes escapes redistribution after ligand stimulation, it has a prolonged half-life to enable sustained signaling from that location [53] . It is possible that the endosomal pool of GIV-GDI has a similarly prolonged half-life, which could explain the unexpectedly high number of complexes predicted at 60 min.
Alternatively, the discrepancy may simply reflect an incompleteness in network modeling. For example, one plausible group of unknown proteins that are missing in our model are downstream phosphatases that presumably act on GIV-GDI on endosomes, and are responsible for the decline in the number of Gα s ·GIV-GDI complexes at later time points. Tables   Table S4: Reactions for Module 1, outlining EGFR activation, internalization, and degradation. In this S3 ).
# Reaction
Reaction flux Kinetic Parameters Ref. 
14 GIV-GEF + EGF·EGFR* 2
[31]
1 Using experimental CDK5 activities [15] , an initial guess was used for the rate, and then refined through fitting simulations to experimental data. 2 Internalization rates were found by fitting simulations to experimental data. 
[56]
Est.
1 Degradation rate set to assumed 30 min half life, assumed no activation through EGFR 2 assumed to be a generic rate of 0.1 s −1 and 1µM 3 Degradation rate of DAG assumed 10x faster when bound to PKC-θ, values were fit using a 10x faster rate as a starting point. S3) , and 3 were fit to Figure S8 .
Reaction flux Kinetic Parameters Ref.
AC↔ AC
[54]
[57]
Est. 
1.75
46 R 2 u→ R 2 uu + 2cAMP
1 κ is the conversion factor from PM to EM 2 Rate was determined through fitting steady state responses to a Hill function, see Figure S8 3 Rates were set to preserve the expected longer timescale events 
[33] Table S10 : Reactions for rapid production of cAMP at the PM (blue line in Figure S5 ) using the dynamics shown in [59] .
# Reaction Reaction flux Kinetic Parameters
Ref.
54
59 Gα s -GDP+GIV-
[24]
1 rates were set the same on PM as on Endosomal Membrane Endosomal membrane experimental immunoblot value 1 All basal steady sates are set by running basal AC stimulation until a stable cAMP, PKA, and PDE response were received. 0.51
0.59 Table S17 : Local sensitivity analysis of cAMP with respect to the model kinetic parameters. The colors indicate the sensitivity to the respective parameter; red indicates that the cAMP production is sensitive to changes in the value of the corresponding parameter (i.e. sensitivity index greater than 1) and blue indicates that cAMP production is partially sensitive to changes in the value of the corresponding parameter (i.e. sensitivity index greater than 0.5) over the time course of signaling. Sensitivity is shown at 5, 15, 30, and 60 min intervals. The index in the square brackets refer to the reaction number. (E) Figure S1 (Supplementary to Figure 1 ): (A-B) Sensitivities of the phenomenological model across time through the variance based sensitivity analysis. Reported sensitivities are shown for both the GIV (A) and no GIV (B) cases. In both the GIV and no GIV cases the highest order sensitivities are shown to always include the degradation and internalization. But, the presence of GIV lowers the AC contribution in the late time scales. (C-D) Total sensitivities of each parameters show the same trend with even higher contributions for both internalization and degradation. Thus, it can be determined that the internalization and degradation rates are key parameters that the system is sensitive to, especially at later times. (E) Variations of the τ delays were performed and the normal distributions of the cAMP profile are reported for the no GIV (green) and GIV (yellow) conditions. . Control (shControl) and GIV-depleted (shGIV) Hela cells expressing GFP-tagged anti-Gα s ·GTP conformational biosensor, nanobody Nb37-GFP were serum starved overnight and stimulated with 50 nM EGF and analyzed by live cell imaging using a Leica scanning disk microscope for 20 min. Freeze frames from representative cells are shown. In the presence of GIV (shControl) little or no Gα s activity was seen after EGF stimulation; however, in GIV-depleted cells, Gα s activity was seen on vesicular structures, likely to be endosomes (arrowheads; see Supplementary Movies 1-2). Bright puncta = active Gα s on endocytic vesicles and/or endosomes. Bar = 10 µm. Comparison of simulation and experimental data for GIV-GEF and GIV-GDI. The concentration of GIV-GEF and GIV-GDI was normalized to its peak value and compared against experimental data (*). Experimental data were obtained from Figures  1D and S1 of [2] , in which protein-protein interaction assays were performed using lysates of cells responding to EGF. (C) Comparison of cAMP time course from simulations and experiments. Simulations of dynamics of the production of cAMP based on the network modules was performed. The concentration of cAMP was normalized to its initial value and compared experimental data in which control or GIV-depleted (shGIV) HeLA cells were serum starved (0.2% FBD, 16h) prior to stimulation with 50nM EGF for the indicated time points. cAMP produced in response to EGF was measured by radioimmunoassay (RIA) as detailed in the main text 'Materials and method' section. Error bars indicated mean S.D of three independent experiments. ns= not significant; * * p=0.01, * * * * p=0.0001. cAMP was normalized against the initial value to ensure the pre-stimulation steady state concentrations of cAMP are satisfied. Tables S12, S15 , S13, S16, S14, S17, S18 for the sensitivities of the fitting components against sensitive parameters. of GIV. Activation of Gα s at the PM alone is predicted to have a rapid activation and inactivation kinetics, while Gα s activation on the endosome membranes is predicted to confer prolonged dynamics over longer time scales. In all cases, the presence/absence of GIV only impacts the prolonged phase, predicting higher Gα s activation without GIV. (D) Simulations of cAMP dynamics that is initiated by the canonical GPCR-stimulated pathway (β2-adrenergic receptor stimulating Gα s ; blue line) and the non-canonical RTK-stimulated pathway that is modulated by GIV-GEM (red lines; solid = with GIV; interrupted = without GIV). In both cases, cAMP values (y axis) were normalized to the max value during a 60 min simulation. Canonical signaling is finite with a predominant PM phase, the non-canonical pathway features prolonged time scales due to a predominant endosomal phase. The interrupted line at approximately 5 min indicates the time period when ligand activated EGFR is typically rapidly endocytosed, marking a watershed between end of PM and beginning of endosomal phase of signaling. (95%CI) were calculated for the fit parameters for both high(solid line) and low (dashed line) bounds. When performing single variable variations, the confidence with respect to cAMP can be classified into 3 classes: (A) sensitive with qualitative change in cAMP dynamics, (B) sensitive without qualitative change in cAMP dynamics, and (C) insensitive. Of the 19 fit, 7 are sensitive, but only 4 change the form of the solution. Of those 4, internalization rate can be treated as a phenomenological constant used to fix time courses (among other steps). This leaves us with three other parameters, that are GIV related, and poorly constrained. These can be explained by the relatively new pathway we are working on and these parameters can be refined as more data is made available. Table S4 ), and (B) rate of Gα s -GDP dependent catalytic degradation of EGFR (reaction number 9 in Table S4 ), (C) receptor internalization rate (reaction number 4 in Table S4 ). The solid line shows the value used in the control model, the dot dashed lines represent a ten-fold increase the value of the parameter from the control value and the dashed lines represent a ten-fold decrease in the value of the kinetic parameter from the control value. Variation of the basal degradation rate of EGFR doesn't affect either the PM or endosomal receptors(A); see also Figure S6 ). Variation of the Gα s -GDP-dependent catalytic degradation rate of EGFR affects the endosomal receptor pool proportionally, with no discernible effect on the PM receptor pool (B; see also Figure S6 ). On the other hand, variation in the rate of internalization of EGFR affects both the PM and endosome pool of receptors. An increase in the rate of internalization of EGFR leads to a rapid decrease in the PM receptor pool with a corresponding rapid increase in the endosome pool of receptors (C). (D) the effect of the binding rate constant of GIV-GEF to ligand-bound, dimerized EGFR (reaction number 14 in Table S5 ) on the dynamics of the formation of the EGFR·GIV·Gα i complex. (E) the effect of CDK5-mediated phosphorylation of GIV to GIV-GEF on the formation of the EGFR·GIV·Gα i complex (k cat reaction number 13 in Table S5 ).(F) Simulations display the effect of PKC-θ-mediated phosphorylation at S1689 for GIV-GEF·EGFR, resulting in conversion of GIV-GEF to GIV-GDI (reaction number 25 in Table S6 ; see also Figure S6 ). Changing this k cat changes the dynamics of the EGFR·GIV·Gα i complex formation such that a decrease in this rate constant leads to a prolonged lifetime of the complex. (G) Variation of the binding rate of GIV-GDI binding rate to G αs -GDP (reaction number 34 in Table S7 ) affects both the density of the bound Gα s ·GIV-GDI molecules and the temporal dynamics. (H) Varying the internalization rate of dimerized EGFR, from the PM to the endosomal compartment (reaction number 4 in Table S4 ) dramatically changes the dynamics of the Gα s ·GIV-GDI complex formation. Faster internalization rates of EGFR lowered the density of the complex and the complexes were assembled earlier than observed in experiments (H). Reducing the rate of EGFR internalization, on the other hand, also lowered the density of Gα s ·GIV-GDI complexes, and they were assembled later. Variations of the internalization of receptors greatly effected cAMP and PKA production within simulations (J,K; blue line) leading to a high (high internalization) or long and low (low internalization) response. (I) The dynamics of the Gα s ·GIV-GDI complex formation are affected by the catalytic degradation rate of internalized dimerized EGFR, which is enabled by Gα s -GDP [10] (reaction number 9 in Table S4 ). The effect of changing this parameter was proportional on both the membrane density of the Gα s ·GIV-GDI complex and affected the peak time and dynamics of the complex formation. Because the degradation of internalized EGFR requires endosomal maturation that is enhanced by Gα s -GDP [10], increasing the rate of Gα s -GDP dependent endosome maturation and EGFR degradation decreased the Gα s -GDI density and increased the rate of the Gα s ·GIV-GDI complex formation, whereas decreasing the rate of the Gα s -GDP-mediated EGFR degradation increased the density of the complex formation and slowed down the process. Variations of the catalytic degradation of receptors greatly effected cAMP and PKA production within simulations (J,K; green line) leading to a low (high degradation) or high and sustained (low degradation) response. Variation of the Gα s ·GIV-GDI interpolation function (reaction number 37 in Table S7 ) affects both the density and timescales of cAMP(L) and Gα s ·GIV-GDI(M) with a high rate leading to an ShGIV type response due to low Gα s ·GIV-GDI densities (M) Figure S10 (Supplementary to Figure 3 ): Concentration of GIV proteins in cells affects peak cAMP time. Simulations were performed by varying the concentration of GIV with values ranging from 0.05 to 10 µM , the peak times for cAMP were then extracted (A). These times were then plotted on a bar graph (B). cAMP peak times were found to shorten and then lengthen with increasing GIV concentrations in a nonlinear manner. The initial, low GIV, peak time decrease is due to the action of Gα s ·GIV-GDI shortening the timescale of Gα s activation. While the later, high GIV, increase is due to the cAMP the action of Gα i inhibition becoming more prevalent over the Gα s generation of cAMP. showed that patients whose tumors had high levels of expression of GIV had a significantly shorter DFS than those with tumors expressing low levels of GIV (all p values < 0.05). See also Figure 5 for patient survival curves for PDE5A isoform and GIV on DFS. Figure S14 (Supplementary to Figure 5 ): GIV mRNA expression is elevated in various cancers. Expression levels of GIV [CCDC88a] mRNA in normal vs. cancers was analyzed in publicly available RNA Seq datasets using Oncomine.org. PMIDs listed under each box plot refers to the original manuscript associated with the dataset. Figure S15 (Supplementary to Figure 5 ) Copy numbers of GIV-gene is elevated in various cancers. Copy numbers of GIV gene is elevated in various cancers. TCGA datasets were analyzed for copy number variations (CNV) in GIV gene [CCDC88a] in normal vs. cancers using Oncomine.org.
